Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ICCC vs INTG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ICCC Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 5–3 Matrix Metrics)

ICCC Overall Winner 6-Pillar Tally: ICCC 4 – 1 INTG (1 Tie) Matrix Metrics: ICCC 5 – 3 INTG

As of Nov 16, 2026, Immucell Corp (ICCC) is the stronger overall head-to-head candidate over Intergroup Corporation (The) (INTG) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). ICCC carries a Unified Composite Score of 43.8/100 (HOLD) at $11.42 (N/M Forward P/E, 15.2% operating margin), whereas INTG carries 32.5/100 (SELL) at $41.48 (N/M Forward P/E, 16.1% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ICCC vs INTG
ICCC NASDAQ Head-to-Head Winner
Immucell Corp
In Vitro & In Vivo Diagnostic Substances
$11.42
+6.23% 1D
Market Cap $97.7M
TTM Revenue $67M
Forward P/E N/M
Beta / 30D Vol 0.24β · 46% Vol
Unified Composite Score
43.8 / 100 HOLD
Tech 15.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 68
RSI-14: 67.5 · SMA20: $10.37 · SMA50: $10.13
INTG NASDAQ
Intergroup Corporation (The)
Operators Of Apartment Buildings
$41.48
-0.65% 1D
Market Cap $89.7M
TTM Revenue $74M
Forward P/E N/M
Beta / 30D Vol -0.14β · 42% Vol
Unified Composite Score
32.5 / 100 SELL
Tech 15.0 Fund 33.0 Flow 50.0 Mom 30.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.7% over 20 days), RSI 70
RSI-14: 70.4 · SMA20: $37.57 · SMA50: $35.37

6-Pillar Scorecard Institutional Category Breakdown (ICCC 4 – 1 INTG)

Columns: Metric · ICCC · INTG
1. Valuation Multiples ICCC
Forward P/E N/M N/M
Trailing P/E 56.6x 58.8x
PEG Ratio N/M N/M
EV / Revenue 1.6x 3.7x
2. Growth & Scale INTG
Revenue Growth (YoY) +11.5% +13.3%
Earnings Growth (YoY) +259.9% N/A
TTM Revenue (USD) $67M $74M
Market Cap $97.7M $89.7M
3. Profitability & Quality ICCC
Gross Margin 40.3% 29.1%
Operating Margin 15.2% 16.1%
Net Profit Margin 2.6% 2.2%
Return on Equity (ROE) 2.6% 0.0%
4. Balance Sheet & Cash Flow ICCC
Cash Generation (TTM) $7.4M $2.8M
Cash Flow Margin 11.0% 3.8%
Net Cash / Leverage $13M Net Debt (0.44x D/E) $186M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat ICCC
OpEx & R&D Intensity 25.1% of Rev ($17M) 13.0% of Rev ($9.6M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Biotechnology Operator Lodging Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ICCC (5) vs INTG (3)
Institutional Metric ICCC INTG Criterion Row Edge
Market Capitalization
Scale
$97.7M $89.7M Larger Scale Tie
Trailing P/E Ratio
Valuation
56.6x 58.8x Lower Multiple ICCC
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+11.5% +13.3% Higher Growth INTG
Operating Margin (TTM)
Profitability
15.2% 16.1% Higher Margin INTG
Net Profit Margin
Profitability
2.6% 2.2% Higher Margin ICCC
Return on Equity (ROE)
Capital Efficiency
2.6% 0.0% Higher ROE ICCC
52-Week Range Position
Momentum
91% ($5–$12) 61% ($25–$52) Stronger Trend ICCC
Beta / 30D Volatility
Risk Regime
0.24β · 46% Vol -0.14β · 42% Vol Lower Realized Risk INTG
Unified Institutional Score
Composite Signal
43.8 / 100 (HOLD) 32.5 / 100 (SELL) Higher Composite ICCC
Trailing 12M Revenue (USD)
Operating Scale
$67M $74M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
40.3% 29.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.6x EV/Rev N/M PEG · 3.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$7.4M ($13M Net Debt (0.44x D/E)) $2.8M ($186M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon INTG +21.87 pp
ICCC: +6.23% · INTG: +28.1%
3M Horizon INTG +1.2 pp
ICCC: +17.01% · INTG: +18.21%
6M Horizon ICCC +4.63 pp
ICCC: +15.24% · INTG: +10.61%
1Y Horizon ICCC +66.8 pp
ICCC: +88.76% · INTG: +21.96%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ICCC Revenue INTG Revenue ICCC Op. Margin INTG Op. Margin Margin Leader
FY2019 $10M $70M -7.0% 20.3% INTG
FY2020 $20M $60M -9.0% 8.4% INTG
FY2021 $20M $30M 1.3% -17.0% ICCC
FY2022 $20M $50M -12.4% 7.8% INTG
FY2023 $20M $60M -32.9% 7.5% INTG
FY2024 $30M $60M -6.2% 2.5% INTG
FY2025 $30M $60M 6.0% 11.9% INTG
FY2026 N/A $70M N/A 16.0% INTG

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ICCC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ICCC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
INTG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact INTG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ICCC Moat Profile Scale & Operating Efficiency Moat
Biotechnology Operator
Competes within the Biotechnology value chain with $97.7M market capitalization and 15.2% operating margin.
OpEx & R&D Reinvestment 25.1% of Rev ($17M)
90D Engineering Disclosures 0 Published
INTG Moat Profile Scale & Operating Efficiency Moat
Lodging Operator
Competes within the Lodging value chain with $89.7M market capitalization and 16.1% operating margin.
OpEx & R&D Reinvestment 13.0% of Rev ($9.6M)
90D Engineering Disclosures 0 Published

Investor FAQ ICCC vs INTG Key Questions & Quantitative Answers

As of Nov 16, 2026, Immucell Corp (ICCC) is the stronger overall head-to-head candidate over Intergroup Corporation (The) (INTG) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). ICCC carries a Unified Composite Score of 43.8/100 (HOLD) at $11.42 (N/M Forward P/E, 15.2% operating margin), whereas INTG carries 32.5/100 (SELL) at $41.48 (N/M Forward P/E, 16.1% operating margin). Technically, ICCC sits in a Markup phase (RSI 67.5, UNCLASSIFIED options structure) and INTG sits in a Markup phase (RSI 70.4, UNCLASSIFIED options structure).

INTG leads the Growth & Scale pillar: ICCC posts +11.5% YoY revenue growth and +259.9% YoY earnings growth on $67M TTM revenue (40.3% gross margin, 15.2% operating margin), compared with INTG at +13.3% YoY revenue growth and N/A YoY earnings growth on $74M TTM revenue (29.1% gross margin, 16.1% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), ICCC cumulative revenue shifted +200.0% while INTG shifted +0.0%. In operating R&D and SG&A reinvestment, ICCC deploys 25.1% of Rev ($17M) (0 90-day corporate R&D disclosures) versus 13.0% of Rev ($9.6M) (0 disclosures) for INTG.

ICCC screens cheaper on headline valuation multiples. ICCC trades at N/M Forward P/E, 56.6x Trailing P/E, N/M PEG, and 1.6x EV/Revenue (11.0% FCF margin), whereas INTG trades at N/M Forward P/E, 58.8x Trailing P/E, N/M PEG, and 3.7x EV/Revenue (3.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ICCC (2.6% ROE) versus INTG (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, ICCC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.24β · 46% Vol realized risk). By comparison, INTG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.14β · 42% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.